Show simple item record

dc.contributor.authorGilson, C
dc.contributor.authorIngleby, F
dc.contributor.authorGilbert, DC
dc.contributor.authorParry, M
dc.contributor.authorAtako, NB
dc.contributor.authorMason, MD
dc.contributor.authorMalik, Z
dc.contributor.authorLangley, RE
dc.contributor.authorSimmons, A
dc.contributor.authorLoehr, A
dc.contributor.authorClarke, Noel W
dc.contributor.authorJames, N
dc.contributor.authorParmar, MKB
dc.contributor.authorSydes, MR
dc.contributor.authorAttard, G
dc.contributor.authorChowdhury, S
dc.date.accessioned2019-11-19T16:01:04Z
dc.date.available2019-11-19T16:01:04Z
dc.date.issued2019en
dc.identifier.citationGilson C, Ingleby F, Gilbert DC, Parry M, Atako NB, Mason MD, et al. Targeted next-generation sequencing (tNGS) of metastatic castrate-sensitive prostate cancer (M1 CSPC): A pilot molecular analysis in the STAMPEDE multi-center clinical trial. J Clin Oncol. 2019;37(15_suppl):5019-.en
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.5019en
dc.identifier.urihttp://hdl.handle.net/10541/622444
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1200/JCO.2019.37.15_suppl.5019en
dc.titleTargeted next-generation sequencing (tNGS) of metastatic castrate-sensitive prostate cancer (M1 CSPC): a pilot molecular analysis in the STAMPEDE multi-center clinical trialen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMRC Clinical Trials Unit at UCL, Londonen
dc.identifier.journalJournal of Clinical Oncologyen


This item appears in the following Collection(s)

Show simple item record